Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Brandner

Showing results (181-190 of 369) with videos related to

Pageof 37
Sort By:
Practical Neurology|January 25, 2024
Nerve biopsy in T-cell lymphoma with neurolymphomatosis: where and whenMenelaos Pipis, Zane Jaunmuktane, Teresa Marafioti, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 14, 2008
Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion diseaseSebastian Brandner, Jerome Whitfield, Ken Boone, et al.
Plos Pathogens|October 3, 2013
Inherited prion disease A117V is not simply a proteinopathy but produces prions transmissible to transgenic mice expressing homologous prion proteinEmmanuel A Asante, Jacqueline M Linehan, Michelle Smidak, et al.
Oncogene|January 29, 2020
Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastomaBarbara Ricci, Thomas O Millner, Nicola Pomella, et al.
Brain : a Journal of Neurology|April 7, 2006
Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion proteinJonathan D F Wadsworth, Susan Joiner, Jacqueline M Linehan, et al.
The Journal of General Virology|February 17, 2009
Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteinsEmmanuel A Asante, Ian Gowland, Andrew Grimshaw, et al.
Neuro-Oncology|September 1, 2021
MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic ReviewSebastian Brandner, Alexandra McAleenan, Claire Kelly, et al.
The EMBO Journal|November 2, 2007
ERK activation causes epilepsy by stimulating NMDA receptor activityAbdolrahman S Nateri, Gennadij Raivich, Christine Gebhardt, et al.
Elife|November 22, 2022
Global hypo-methylation in a proportion of glioblastoma enriched for an astrocytic signature is associated with increased invasion and altered immune landscapeJames Boot, Gabriel Rosser, Dailya Kancheva, et al.
The New England Journal of Medicine|January 19, 2017
Variant Creutzfeldt-Jakob Disease in a Patient with Heterozygosity at PRNP Codon 129Tzehow Mok, Zane Jaunmuktane, Susan Joiner, et al.
Pageof 37

Showing results (181-190 of 369) with videos related to

Sort By:
Pageof 37
Practical Neurology|January 25, 2024
Nerve biopsy in T-cell lymphoma with neurolymphomatosis: where and whenMenelaos Pipis, Zane Jaunmuktane, Teresa Marafioti, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 14, 2008
Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion diseaseSebastian Brandner, Jerome Whitfield, Ken Boone, et al.
Plos Pathogens|October 3, 2013
Inherited prion disease A117V is not simply a proteinopathy but produces prions transmissible to transgenic mice expressing homologous prion proteinEmmanuel A Asante, Jacqueline M Linehan, Michelle Smidak, et al.
Oncogene|January 29, 2020
Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastomaBarbara Ricci, Thomas O Millner, Nicola Pomella, et al.
Brain : a Journal of Neurology|April 7, 2006
Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion proteinJonathan D F Wadsworth, Susan Joiner, Jacqueline M Linehan, et al.
The Journal of General Virology|February 17, 2009
Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteinsEmmanuel A Asante, Ian Gowland, Andrew Grimshaw, et al.
Neuro-Oncology|September 1, 2021
MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic ReviewSebastian Brandner, Alexandra McAleenan, Claire Kelly, et al.
The EMBO Journal|November 2, 2007
ERK activation causes epilepsy by stimulating NMDA receptor activityAbdolrahman S Nateri, Gennadij Raivich, Christine Gebhardt, et al.
Elife|November 22, 2022
Global hypo-methylation in a proportion of glioblastoma enriched for an astrocytic signature is associated with increased invasion and altered immune landscapeJames Boot, Gabriel Rosser, Dailya Kancheva, et al.
The New England Journal of Medicine|January 19, 2017
Variant Creutzfeldt-Jakob Disease in a Patient with Heterozygosity at PRNP Codon 129Tzehow Mok, Zane Jaunmuktane, Susan Joiner, et al.
Pageof 37